Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thrombin | 8 | 2016 | 598 | 2.010 |
Why?
|
| Glycomics | 4 | 2020 | 121 | 1.160 |
Why?
|
| Lignin | 3 | 2016 | 17 | 1.130 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 3 | 2016 | 141 | 1.110 |
Why?
|
| Microarray Analysis | 5 | 2024 | 767 | 0.990 |
Why?
|
| Polysaccharides | 11 | 2024 | 1053 | 0.950 |
Why?
|
| Microwaves | 1 | 2024 | 191 | 0.860 |
Why?
|
| Tyrosine | 2 | 2023 | 1461 | 0.680 |
Why?
|
| Glycopeptides | 1 | 2020 | 224 | 0.670 |
Why?
|
| Glycoproteins | 3 | 2021 | 2263 | 0.610 |
Why?
|
| Antithrombins | 3 | 2015 | 304 | 0.580 |
Why?
|
| Anticoagulants | 4 | 2016 | 4599 | 0.560 |
Why?
|
| Software | 2 | 2020 | 4443 | 0.520 |
Why?
|
| Data Mining | 1 | 2019 | 537 | 0.490 |
Why?
|
| Platelet Aggregation | 2 | 2016 | 798 | 0.480 |
Why?
|
| Glycosylation | 6 | 2024 | 1126 | 0.460 |
Why?
|
| Blood Coagulation | 4 | 2016 | 1127 | 0.430 |
Why?
|
| Drug Design | 4 | 2013 | 1076 | 0.420 |
Why?
|
| Carrier Proteins | 1 | 2024 | 5021 | 0.370 |
Why?
|
| Sulfates | 3 | 2016 | 390 | 0.340 |
Why?
|
| Lectins, C-Type | 2 | 2022 | 588 | 0.320 |
Why?
|
| Allosteric Regulation | 6 | 2016 | 408 | 0.320 |
Why?
|
| Thromboembolism | 1 | 2013 | 986 | 0.290 |
Why?
|
| Heparin | 3 | 2016 | 1637 | 0.240 |
Why?
|
| Factor XIa | 2 | 2014 | 8 | 0.240 |
Why?
|
| Trichuris | 1 | 2024 | 32 | 0.240 |
Why?
|
| Benzofurans | 3 | 2014 | 140 | 0.240 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2020 | 1572 | 0.230 |
Why?
|
| Phosphorylcholine | 1 | 2024 | 162 | 0.230 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 3068 | 0.220 |
Why?
|
| Protein Binding | 6 | 2023 | 9386 | 0.210 |
Why?
|
| Antibodies | 2 | 2020 | 2460 | 0.210 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2013 | 179 | 0.200 |
Why?
|
| Lectins | 1 | 2024 | 513 | 0.200 |
Why?
|
| Mannose-Binding Lectins | 1 | 2021 | 100 | 0.190 |
Why?
|
| Allosteric Site | 3 | 2016 | 103 | 0.190 |
Why?
|
| Galectin 3 | 1 | 2022 | 227 | 0.190 |
Why?
|
| Protease Inhibitors | 2 | 2016 | 791 | 0.180 |
Why?
|
| Fluorescence Polarization | 1 | 2020 | 132 | 0.180 |
Why?
|
| Hydrolysis | 3 | 2016 | 682 | 0.180 |
Why?
|
| Glycosyltransferases | 1 | 2020 | 113 | 0.180 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2019 | 90 | 0.170 |
Why?
|
| Serum | 1 | 2020 | 214 | 0.170 |
Why?
|
| Oligosaccharides | 1 | 2021 | 414 | 0.170 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2019 | 177 | 0.170 |
Why?
|
| Propylamines | 1 | 2019 | 165 | 0.170 |
Why?
|
| Peptide Library | 1 | 2020 | 349 | 0.170 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2020 | 503 | 0.160 |
Why?
|
| Carbohydrates | 1 | 2020 | 394 | 0.160 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2016 | 22 | 0.150 |
Why?
|
| Fluorescence | 1 | 2019 | 751 | 0.150 |
Why?
|
| Binding Sites | 5 | 2020 | 6114 | 0.140 |
Why?
|
| Thrombelastography | 2 | 2016 | 164 | 0.140 |
Why?
|
| Molecular Mimicry | 2 | 2014 | 201 | 0.140 |
Why?
|
| Bleeding Time | 1 | 2016 | 89 | 0.140 |
Why?
|
| Kinetics | 5 | 2015 | 6473 | 0.130 |
Why?
|
| Coumarins | 1 | 2016 | 119 | 0.130 |
Why?
|
| Catalytic Domain | 2 | 2016 | 698 | 0.130 |
Why?
|
| Thermodynamics | 2 | 2014 | 596 | 0.130 |
Why?
|
| Glycosaminoglycans | 2 | 2016 | 624 | 0.130 |
Why?
|
| Propionates | 1 | 2015 | 169 | 0.130 |
Why?
|
| Glucuronic Acid | 1 | 2015 | 148 | 0.130 |
Why?
|
| Blood Coagulation Tests | 1 | 2016 | 263 | 0.130 |
Why?
|
| Antigens | 1 | 2020 | 1466 | 0.120 |
Why?
|
| Workflow | 1 | 2019 | 847 | 0.120 |
Why?
|
| Protein Conformation | 4 | 2016 | 4011 | 0.120 |
Why?
|
| Static Electricity | 1 | 2014 | 267 | 0.120 |
Why?
|
| Prodrugs | 1 | 2015 | 268 | 0.120 |
Why?
|
| Enoxaparin | 1 | 2016 | 377 | 0.110 |
Why?
|
| Platelet-Rich Plasma | 1 | 2016 | 177 | 0.110 |
Why?
|
| Documentation | 1 | 2019 | 871 | 0.110 |
Why?
|
| Sulfuric Acid Esters | 1 | 2013 | 33 | 0.110 |
Why?
|
| Hemostasis | 1 | 2016 | 458 | 0.110 |
Why?
|
| Structure-Activity Relationship | 3 | 2013 | 3129 | 0.110 |
Why?
|
| Antirheumatic Agents | 1 | 2023 | 1339 | 0.110 |
Why?
|
| Patents as Topic | 1 | 2013 | 103 | 0.110 |
Why?
|
| Binding, Competitive | 1 | 2014 | 1157 | 0.110 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 281 | 0.110 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 3768 | 0.100 |
Why?
|
| Sodium Chloride | 1 | 2014 | 625 | 0.100 |
Why?
|
| Platelet Activation | 1 | 2016 | 673 | 0.100 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2012 | 91 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 1990 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 2866 | 0.100 |
Why?
|
| Legislation, Drug | 1 | 2013 | 206 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 977 | 0.100 |
Why?
|
| Animals | 11 | 2024 | 168757 | 0.100 |
Why?
|
| Aniline Compounds | 1 | 2015 | 986 | 0.100 |
Why?
|
| Sucrose | 1 | 2011 | 164 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 1723 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 1157 | 0.090 |
Why?
|
| Hemoglobins | 1 | 2015 | 1534 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 720 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 2014 | 1227 | 0.080 |
Why?
|
| Molecular Structure | 1 | 2013 | 1899 | 0.080 |
Why?
|
| Glucosides | 1 | 2013 | 451 | 0.080 |
Why?
|
| Internet | 1 | 2020 | 3064 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 2025 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2023 | 3712 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2015 | 2132 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 2203 | 0.070 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 2158 | 0.070 |
Why?
|
| Mice | 4 | 2023 | 81183 | 0.060 |
Why?
|
| Heparitin Sulfate | 2 | 2016 | 225 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6622 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2016 | 3461 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9687 | 0.060 |
Why?
|
| Factor Xa | 2 | 2015 | 162 | 0.050 |
Why?
|
| 4-1BB Ligand | 1 | 2022 | 29 | 0.050 |
Why?
|
| Mannose | 1 | 2022 | 124 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2016 | 6196 | 0.050 |
Why?
|
| Humans | 19 | 2023 | 744343 | 0.050 |
Why?
|
| Thrombosis | 1 | 2016 | 2968 | 0.050 |
Why?
|
| Carbohydrate Sequence | 2 | 2013 | 414 | 0.050 |
Why?
|
| Models, Molecular | 3 | 2021 | 5456 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2012 | 459 | 0.050 |
Why?
|
| Galectins | 1 | 2023 | 268 | 0.050 |
Why?
|
| Carbohydrate Conformation | 1 | 2019 | 208 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2022 | 595 | 0.040 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 157 | 0.040 |
Why?
|
| Immune System | 1 | 2024 | 805 | 0.040 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 367 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2019 | 1386 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 21827 | 0.040 |
Why?
|
| Chickens | 1 | 2019 | 865 | 0.040 |
Why?
|
| Heparin Lyase | 1 | 2016 | 37 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13102 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2019 | 648 | 0.030 |
Why?
|
| Polymerization | 1 | 2016 | 164 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 598 | 0.030 |
Why?
|
| Influenza A virus | 1 | 2019 | 456 | 0.030 |
Why?
|
| Biotransformation | 1 | 2015 | 168 | 0.030 |
Why?
|
| Cattle | 2 | 2012 | 3922 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 1836 | 0.030 |
Why?
|
| Heparin Cofactor II | 1 | 2015 | 3 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 1537 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2019 | 1035 | 0.030 |
Why?
|
| Ligands | 1 | 2021 | 3282 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 2016 | 355 | 0.030 |
Why?
|
| Swine | 1 | 2024 | 5917 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2540 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2022 | 4204 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3200 | 0.030 |
Why?
|
| Epitopes | 1 | 2019 | 2571 | 0.030 |
Why?
|
| Digestion | 1 | 2012 | 54 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2023 | 4161 | 0.030 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 738 | 0.030 |
Why?
|
| Carboxylic Acids | 1 | 2012 | 97 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 276 | 0.030 |
Why?
|
| Dimerization | 1 | 2013 | 893 | 0.020 |
Why?
|
| Ultracentrifugation | 1 | 2011 | 182 | 0.020 |
Why?
|
| Prothrombin Time | 1 | 2011 | 119 | 0.020 |
Why?
|
| Partial Thromboplastin Time | 1 | 2011 | 206 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2019 | 2455 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3479 | 0.020 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2011 | 339 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 29786 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2013 | 1801 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 689 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 976 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 18111 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4560 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2019 | 1479 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2019 | 8436 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3701 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 2011 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2014 | 1058 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 7729 | 0.020 |
Why?
|
| Proteins | 1 | 2020 | 6103 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 3760 | 0.010 |
Why?
|
| Algorithms | 1 | 2015 | 13881 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 56430 | 0.010 |
Why?
|
| Male | 2 | 2020 | 350118 | 0.010 |
Why?
|
| Female | 2 | 2020 | 380194 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 213383 | 0.000 |
Why?
|
| Adult | 1 | 2020 | 214055 | 0.000 |
Why?
|
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_